BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32783550)

  • 41. Mammographic features of calcifications in DCIS: correlation with oestrogen receptor and human epidermal growth factor receptor 2 status.
    Bae MS; Moon WK; Chang JM; Cho N; Park SY; Won JK; Jeon YK; Moon HG; Han W; Park IA
    Eur Radiol; 2013 Aug; 23(8):2072-8. PubMed ID: 23512196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sentinel node biopsy in ductal carcinoma in situ of the breast: Never justified?
    Sorrentino L; Sartani A; Bossi D; Amadori R; Nebuloni M; Truffi M; Bonzini M; Riggio E; Foschi D; Corsi F
    Breast J; 2018 May; 24(3):325-333. PubMed ID: 29024241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ductal carcinoma in situ diagnosed by breast needle biopsy: Predictors of invasion in the excision specimen.
    Doebar SC; de Monyé C; Stoop H; Rothbarth J; Willemsen SP; van Deurzen CH
    Breast; 2016 Jun; 27():15-21. PubMed ID: 27212695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Qualitative Radiogenomics: Association Between BI-RADS Calcification Descriptors and Recurrence Risk as Assessed by the Oncotype DX Ductal Carcinoma In Situ Score.
    Woodard GA; Price ER
    AJR Am J Roentgenol; 2019 Apr; 212(4):919-924. PubMed ID: 30714832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of Upstaged Ductal Carcinoma In Situ Using Forced Labeling and Domain Adaptation.
    Hou R; Mazurowski MA; Grimm LJ; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    IEEE Trans Biomed Eng; 2020 Jun; 67(6):1565-1572. PubMed ID: 31502960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flat epithelial atypia on core needle biopsy does not always mandate excisional biopsy.
    Srour MK; Donovan C; Chung A; Harit A; Dadmanesh F; Giuliano AE; Amersi F
    Breast J; 2020 Apr; 26(4):679-684. PubMed ID: 31562689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ductal Carcinoma In Situ Biology, Language, and Active Surveillance: A Survey of Breast Radiologists' Knowledge and Opinions.
    Grimm LJ; Destounis SV; Rahbar H; Soo MS; Poplack SP
    J Am Coll Radiol; 2020 Oct; 17(10):1252-1258. PubMed ID: 32278849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inter-reader Variability in the Use of BI-RADS Descriptors for Suspicious Findings on Diagnostic Mammography: A Multi-institution Study of 10 Academic Radiologists.
    Lee AY; Wisner DJ; Aminololama-Shakeri S; Arasu VA; Feig SA; Hargreaves J; Ojeda-Fournier H; Bassett LW; Wells CJ; De Guzman J; Flowers CI; Campbell JE; Elson SL; Retallack H; Joe BN
    Acad Radiol; 2017 Jan; 24(1):60-66. PubMed ID: 27793579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative MRI of pure intraductal breast carcinoma--a valuable adjunct to mammography in assessing cancer extent.
    Santamaría G; Velasco M; Farrús B; Zanón G; Fernández PL
    Breast; 2008 Apr; 17(2):186-94. PubMed ID: 17964786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
    Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
    Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
    Kuhl CK; Schrading S; Bieling HB; Wardelmann E; Leutner CC; Koenig R; Kuhn W; Schild HH
    Lancet; 2007 Aug; 370(9586):485-92. PubMed ID: 17693177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ.
    Lee SA; Lee Y; Ryu HS; Jang MJ; Moon WK; Moon HG; Lee SH
    Radiology; 2022 Nov; 305(2):307-316. PubMed ID: 35787199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
    Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
    Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simplifying Breast Imaging Reporting and Data System classification of mammograms with pure suspicious calcifications.
    Menezes GL; Winter-Warnars GA; Koekenbier EL; Groen EJ; Verkooijen HM; Pijnappel RM
    J Med Screen; 2018 Jun; 25(2):82-87. PubMed ID: 28691862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ductal carcinoma in situ on digital mammography versus digital breast tomosynthesis: rates and predictors of pathologic upgrade.
    Kim G; Mikhael PG; Oseni TO; Bahl M
    Eur Radiol; 2020 Nov; 30(11):6089-6098. PubMed ID: 32591884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
    King TA; Farr GH; Cederbom GJ; Smetherman DH; Bolton JS; Stolier AJ; Fuhrman GM
    Am Surg; 2001 Sep; 67(9):907-12. PubMed ID: 11565774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging.
    Menell JH; Morris EA; Dershaw DD; Abramson AF; Brogi E; Liberman L
    Breast J; 2005; 11(6):382-90. PubMed ID: 16297080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical biopsy is still necessary for BI-RADS 4 calcifications found on digital mammography that are technically too faint for stereotactic core biopsy.
    Jeffries DO; Neal CH; Noroozian M; Joe AI; Pinsky RW; Goodsitt MM; Helvie MA
    Breast Cancer Res Treat; 2015 Dec; 154(3):557-61. PubMed ID: 26589316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
    Jakub JW; Murphy BL; Gonzalez AB; Conners AL; Henrichsen TL; Maimone S; Keeney MG; McLaughlin SA; Pockaj BA; Chen B; Musonza T; Harmsen WS; Boughey JC; Hieken TJ; Habermann EB; Shah HN; Degnim AC
    Ann Surg Oncol; 2017 Oct; 24(10):2915-2924. PubMed ID: 28766196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?
    Graña-López L; Herranz M; Domínguez-Prado I; Argibay S; Villares Á; Vázquez-Caruncho M
    Eur Radiol; 2020 Jan; 30(1):514-522. PubMed ID: 31375867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.